scholarly article | Q13442814 |
P50 | author | Hadi Al-Hasani | Q90213489 |
P2093 | author name string | Jin Wang | |
Christopher P Corpe | |||
Mark Levine | |||
Peter Eck | |||
P2860 | cites work | GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues | Q22253166 |
Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors | Q27865317 | ||
Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes | Q28115284 | ||
Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid | Q28116082 | ||
A family of mammalian Na+-dependent L-ascorbic acid transporters | Q28144223 | ||
Molecular and functional roles of duodenal cytochrome B (Dcytb) in iron metabolism | Q28204979 | ||
Targeting of GLUT6 (formerly GLUT9) and GLUT8 in rat adipose cells | Q28346426 | ||
Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2 | Q28574811 | ||
Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and Glucose | Q28578597 | ||
Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival | Q28587083 | ||
Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine | Q30829378 | ||
Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice | Q33761086 | ||
Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. | Q34591663 | ||
Xenopus oocyte microinjection: from gene to protein | Q35849278 | ||
Vitamin C in mouse and human red blood cells: an HPLC assay | Q36061661 | ||
Recent advances in intestinal iron transport | Q36259666 | ||
Facilitated hexose transporters: new perspectives on form and function | Q36910739 | ||
The role of Dcytb in iron metabolism: an update | Q37330389 | ||
Human erythrocyte membranes contain a cytochrome b561 that may be involved in extracellular ascorbate recycling | Q40215007 | ||
Genistein inhibits insulin-stimulated glucose transport and decreases immunocytochemical labeling of GLUT4 carboxyl-terminus without affecting translocation of GLUT4 in isolated rat adipocytes: additional evidence of GLUT4 activation by insulin | Q42509613 | ||
Expression of GLUT8 in mouse intestine: identification of alternative spliced variants | Q42802970 | ||
Very low vitamin C activity of orally administered L-dehydroascorbic acid | Q43831882 | ||
Recycling of vitamin C by mammalian thioredoxin reductase | Q43920316 | ||
Antiscorbutic effect of dehydro-L-ascorbic acid in vitamin C-deficient guinea pigs. | Q44236934 | ||
6-Bromo-6-deoxy-L-ascorbic acid: an ascorbate analog specific for Na+-dependent vitamin C transporter but not glucose transporter pathways | Q45182327 | ||
Mouse GLUT9: evidences for a urate uniporter. | Q45935171 | ||
The antiscorbutic action of L-ascorbic acid and D-isoascorbic acid (erythorbic acid) in the guinea pig. | Q46432588 | ||
Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins | Q48418596 | ||
Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid | Q49140908 | ||
Ascorbic acid analysis using high-performance liquid chromatography with coulometric electrochemical detection | Q69802188 | ||
Degradation of dehydroascorbate to 2,3-diketogulonate in blood circulation | Q77545868 | ||
Flavonoids are potential inhibitors of glucose uptake in U937 cells | Q77994864 | ||
Clinical Usefulness of the Oral Ascorbic Acid Tolerance Test in Scurvy | Q78850368 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Solute carrier family 2, (facilitated glucose transporter), member 8 | Q21106288 |
glucose transmembrane transport | Q21972891 | ||
Solute carrier family 2 member 2 | Q22676733 | ||
P304 | page(s) | 9092-9101 | |
P577 | publication date | 2013-02-08 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. | |
P478 | volume | 288 |
Q51694483 | A Minireview: Usefulness of Transporter-Targeted Prodrugs in Enhancing Membrane Permeability. |
Q46529265 | Ascorbate pool, sugars and organic acids in black currant (Ribes nigrum L.) berries are strongly influenced by genotype and post-flowering temperature |
Q57169600 | Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly |
Q38784700 | Ascorbic acid intake and oxalate synthesis |
Q41688368 | Chemical Transport Knockout for Oxidized Vitamin C, Dehydroascorbic Acid, Reveals Its Functions in vivo |
Q92704085 | Combination Therapy with Vitamin C Could Eradicate Cancer Stem Cells |
Q40126406 | Effects of High Doses of Vitamin C on Cancer Patients in Singapore: Nine Cases |
Q36670980 | Genetic Variation in Human Vitamin C Transporter Genes in Common Complex Diseases. |
Q90647792 | Glucose transporter 2 in common carp (Cyprinus carpio L.): molecular cloning, tissue expression, and the responsiveness to glucose, insulin, and glucagon |
Q35332452 | Identification of vitamin C transporters in the human airways: a cross-sectional in vivo study |
Q35175163 | Intravenous Vitamin C and Cancer: A Systematic Review |
Q36540948 | Low Red Blood Cell Vitamin C Concentrations Induce Red Blood Cell Fragility: A Link to Diabetes Via Glucose, Glucose Transporters, and Dehydroascorbic Acid |
Q37629916 | Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease |
Q37420554 | Myths, artifacts, and fatal flaws: identifying limitations and opportunities in vitamin C research |
Q90297021 | Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence |
Q92619526 | Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations |
Q36398157 | Protective effect of rosiglitazone, quercetin, and their combination on fructose-induced metabolic syndrome in rats |
Q33917658 | Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? |
Q37476025 | SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy. |
Q37357911 | Synthetic or food-derived vitamin C - are they equally bioavailable? |
Q92920937 | The Emerging Role of Vitamin C as a Treatment for Sepsis |
Q90633435 | The Pharmacokinetics of Vitamin C |
Q45264841 | The SLC2A14 gene, encoding the novel glucose/dehydroascorbate transporter GLUT14, is associated with inflammatory bowel disease. |
Q92890565 | The cyanobacterial neurotoxin β-N-methylamino-l-alanine prevents addition of heparan sulfate to glypican-1 and increases processing of amyloid precursor protein in dividing neuronal cells |
Q37411052 | The human sodium-dependent ascorbic acid transporters SLC23A1 and SLC23A2 do not mediate ascorbic acid release in the proximal renal epithelial cell. |
Q37563440 | The hypoxia-inducible factor renders cancer cells more sensitive to vitamin C-induced toxicity. |
Q60934196 | The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome |
Q57169441 | Vitamin C and Infection: Current Knowledge and Future Prospects |
Q64268237 | Vitamin C as a Modulator of the Response to Cancer Therapy |
Q26771512 | Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain |
Q38710779 | Vitamin C: the known and the unknown and Goldilocks |